Board Meeting13 May 2026, 11:38 am
Genpharmasec Ltd Board Meeting on May 21, 2026 to Approve Results
AI Summary
Genpharmasec Ltd has scheduled a Board of Directors meeting on May 21, 2026, to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The meeting will also address other business matters with the Chairman's permission. The trading window for directors and designated persons has been closed from April 1, 2026, until 48 hours after the declaration of the financial results.
Key Highlights
- Board meeting scheduled for May 21, 2026, to approve financial results.
- Audited standalone and consolidated results for the year ended March 31, 2026, to be considered.
- Trading window closed from April 1, 2026, until 48 hours post results declaration.
- Meeting to address other business matters with Chairman's approval.
Price Impact
More from GENPHARMA